Cost–effective strategies for designing novel drug delivery systems that target a broad range of disease conditions
In vivo imaging has become an important tool for the development of new drug delivery systems, shedding new light on the pharmacokinetics, biodistribution, bioavailability, local concentration, and clearance of drug substances for the treatment of human disease, most notably cancer. Written by a team of international experts, this book examines the use of quantitative imaging techniques in designing and evaluating novel drug delivery systems and applications.
Drug Delivery Applications of Noninvasive Imaging offers a full arsenal of tested and proven methods, practices and guidance, enabling readers to overcome the many challenges in creating successful new drug delivery systems. The book begins with an introduction to molecular imaging. Next, it covers:
- In vivo imaging techniques and quantitative analysis
- Imaging drugs and drug carriers at the site of action, including low–molecular weight radiopharmaceuticals, peptides and proteins, siRNA, cells, and nanoparticles
- Applications of imaging techniques in administration routes other than intravenous injection, such as pulmonary and oral delivery
- Translational research leading to clinical applications
- Imaging drug delivery in large animal models
- Clinical applications of imaging techniques to guide drug development and drug delivery
Chapters are based on a thorough review of the current literature as well as the authors′ firsthand experience working with imaging techniques for the development of novel drug delivery systems.
Presenting state–of–the–technology applications of imaging in preclinical and clinical evaluation of drug delivery systems, Drug Delivery Applications of Noninvasive Imaging offers cost–effective strategies to pharmaceutical researchers and students for developing drug delivery systems that accurately target a broad range of disease conditions.
1 Introduction to Molecular Imaging 1Vikas Kundra
2 PET/SPECT: Instrumentation and Imaging Techniques 12Yuan–Chuan Tai
3 Photoacoustic Tomography and Its Applications in Drug Delivery and Photothermal Therapy 45Liang Song and Lihong V. Wang
4 Raman Microspectral Imaging for Label–Free Detection of Nanoparticle–Mediated Cellular and Subcellular Drug Delivery 70Tatyana Chernenko, Lara Milane, Christian Matthäus, Max Diem, and Mansoor Amiji
5 A natomical and Functional MRI91Edward F. Jackson
6 Quantitative Imaging in Drug Delivery 125Kooresh I. Shoghi
7 PET Imaging of the Pharmacokinetics of Small Molecular–Weight Drugs 147Stephen M. Moerlein and Zhude Tu
8 Imaging Peptides, Proteins, and Antibody Delivery 192Frederik L. Giesel and Clemens Kratochwil
9 In Vivo Imaging and Delivery of siRNA199Zdravka Medarova and Anna Moore
10 Imaging Cell Therapy 223Yajie Liang and Jeff W. M. Bulte
11 Radiolabeled Liposomes as Drug Delivery Nanotheranostics 252William T. Phillips, Ande Bao, Keitaro Sou, Shihong Li, and Beth Goins
12 Polymeric Micelles as Imaging Agents and Drug Delivery Systems 268Jun Zhao and Chun Li
13 Perfluorocarbon Nanoparticles: Translating Bench Opportunities to the Clinic 296G. M. Lanza, P. M. Winter, S. D. Caruthers, A. H. Schmieder, and S. A. Wickline
14 Cancer Theranostics with Hollow Gold Nanospheres 308Wei Lu and Chun Li
15 Imaging Pulmonary Drug Delivery 333Stephen P. Newman
16 In Vivo Imaging for Validation of Oral Dose Performance 367Fiona J. McInnes and Howard N. E. Stevens
17 Role of Large Animal Models in Translational Studies of Imaging and Targeted Drug Delivery 389Rajesh K. Uthamanthil and Mei Tian
18 Imaging Transcatheter Delivery to Liver Tumors 412Adil Al–Nahhas, Meeran Naji, and Imene Zerizer
19 Direct Visualization of Therapeutic Radionuclide Distribution Using Nuclear Medicine Imaging: I–131 in Metastatic Thyroid Carcinoma 426Ho Young Lee, June–Key Chung, So Won Oh, Jong Jin Lee, Keon Wook Kang, Do Joon Park, Bo Youn Cho, and Myung Chul Lee
20 Imaging Drug Delivery to the CNS Using Translational Positron Emission Tomography Studies 432Chi–Ming Lee, Katarina Varnäs, and Lars Farde
CHUN LI, PhD, is Professor and Ad Interim Chief, Chemistry Section, in the Department of Cancer Systems Imaging at the University of Texas MD Anderson Cancer Center. He is Associate Editor of Cancer Nanotechnology and a member of the editorial boards of American Journal of Nuclear Medicine and Molecular Imaging and Quantitative Imaging in Medicine and Surgery. Dr. Li has more than 120 peer–reviewed publications and holds twenty–eight patents.
MEI TIAN, MD, is Vice President of Hangzhou Binjiang Hospital and Professor of Diagnostic Imaging and Nuclear Medicine at The Second Hospital, Zhejiang University School of Medicine. Dr. Tian is also an editorial consultant for The Lancet. She is a member of the editorial boards of Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine Communications, and Oncology.